Learn More
Medchemexpress LLC 3-(5-methyl-thiazol-2-yl)-5-[3R-oxolan-3-yl]oxy-N-[1R-1-(2-CF3-pyrimidin-5-yl)ethyl]benzamide | 1948229-21-7 | 99.9% | 478.5 g/mol | C22H21F3N4O3S | 5 MG

Supplier: Medchemexpress LLC HY1091705MG
Eliapixant (BAY 1817080) is an investigational small-molecule antagonist of the P2X3 purinergic receptor. It has been studied in clinical and preclinical research for refractory chronic cough and other sensory neuropathic conditions. This compound is intended for laboratory research use only and is not approved for clinical use.
- Potent P2X3 receptor antagonist with reported IC50 approximately 8 nM.
- Useful for research on refractory chronic cough and sensory neuropathic conditions.
- High reported purity (99.95%) suitable for analytical and preclinical studies.
- Available in small research pack sizes for experimental workflows.
- Molecular weight 478.5 g/mol; formula C22H21F3N4O3S.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.